ALG5 and Hepatic cysts: F200 subjects II.4, II.11, and II.13 have preserved eGFR, no kidney cysts, and WT-ALG5; however, II.4 and II.11 developed liver cysts at age 76 and 69 years, respectively (Figure 2).